Aptamer Share Discussion Threads

[purchaseatthetop] 10/12/2024 07:27

8/7/24 RNS
“Upturn in sales and order book as the year progressed

The unaudited revenue for the year was approximately £0.85 million with £0.55 million generated in the second half of the year. Following the lull in customer confidence caused by the acute funding problem in August 2023, confidence had to be rebuilt with customers which translated into the rebuilding of the sales pipeline. These efforts have led to increased revenues in the second half of the year and an encouraging rise in order book values. In the last quarter of the financial year, £0.98 million in orders were won which has resulted in a total of £1.8 million in signed orders currently being processed or awaiting processing in the laboratory.”

I repeat my question. Given the 8/7/24 details how come actual revenue in the next 12 months is just £1.2m? I would never have looked at this company had it not been for Dplewis trolling me so you can thank him for making me have a look. Now I am simply fascinated.

[dplewis1] 10/12/2024 07:08

Ah there he is. Funny that Proactive is "paid propaganda" when he's trolling but it's the gospel when it's in a share he's ramping (cough cough Enet). Bought at 50p and sold at 0.5p great work there buffett..

[roughandtumbleone] 10/12/2024 06:52

Maybe you should watch this and understand that development costs are being picked up by the Customer with this application he's referring to.Don't let the facts blur your vision. https://www.proactiveinvestors.co.uk/companies/news/1060119/aptamer-ceo-dr-arron-tolley-on-extended-deal-with-genetic-medicines-customer-growing-pipeline-1060119.html

[purchaseatthetop] 10/12/2024 06:14

Just to bring some realism here. Aug 24 RNS
“Additional financing

The Group expects to incur significant costs in connection with development, commercialisation and intellectual property protection of its technology. The Group's working capital requirements depend on numerous factors, including the rate of market acceptance of its services, its ability to attract customers and other factors that may be outside of the Group's control. The Group may require additional financing in the medium to long term, whether from equity or debt sources, to finance working capital requirements or to finance its growth through future stages of development.”

Right now they are burning cash at £260k a month excluding these significant costs. By Jan 25 half the Aug 24 placing cash will be gone. They had £870k at 30/6/24 and were down to fumes at the cash raise so rapidly emptying the bank account.

The failure to state cash runway except for saying it is “generous̶1; makes me think another cash raise is not far off. Certainly by end Q1 25. The RNS yesterday giving £200k to Hargreaves is simply astounding. No wonder he was obliged to buy some aswell to make it look really positive.

Just my view of course!

[roughandtumbleone] 10/12/2024 03:56

https://www.share-talk.com/rns-hotlist-with-zak-mir-ccz-eml-cel-ntvo-rock-apta-ensi-sdx/A small write up in Sharetalk on their "Hotlist"

[roughandtumbleone] 10/12/2024 03:52

The fact the Non Executive Chairman purchased shares along with the CEO also buying yesterday, is great news but reading the announcements and details, there's clearly a huge amount going on behind the scenes across many streams. The new Scientific Advisory Board is also a smart move adding all of the technical knowledge and combining that with those with the commercial acumen to drive the science forward.The current Market Cap is tiny given the potential.

[kingston78] 09/12/2024 19:19

I have looked at the 5 year historical chart. It was at about 150 p at its highest. I think there must have been various placings since, but nonetheless, it is astonishing how far the share has fallen to the current sub-penny status. On some sustained positive news flow it is not out of imagination that it will climb to the 10 p level in the future.

[gepetto100] 09/12/2024 18:20

Paul - well aware of that I was thinking more of an expansion of on the material research announced last week that the Doc gave

[paul planet earth 1] 09/12/2024 17:37

Gepetto - I doubt any surprises are incoming as directors can’t buy in a closed period if there’s material news on the way. Nonetheless, happy with the rise here

[gepetto100] 09/12/2024 17:34

Big vote of confidence with the director buys today they obviously are happy with the progress with the big pharmaceuticalsI just wonder if well get a bit of a surprise on Friday at the webinar

[bones698] 09/12/2024 15:37

Directors buying if they continue to add will get interesting very quickly Tolley buying a few now .

[bones698] 09/12/2024 14:44

Yes it's ridiculous to think it's not cap is under 7m even now and shows the huge possibilities here . 1p would be 16m mkt cap . There are companies out there worth ten times what apta is with less revenue,and deals with majors . It will get there just need to be patient

[someuwin] 09/12/2024 14:25

Still less than £7m mkt cap. Amazing.

[bones698] 09/12/2024 14:13

Level two on fire they want shares

[dplewis1] 09/12/2024 14:02

Don't worry, patt will soon show up with his standard "wrong take" .. this is up 50% since he started chirping

[bones698] 09/12/2024 13:54

Wow nice rns director dealing bought 19m at 0.31 this is going to move. So many bullish signs here at some point this will pop

[bones698] 09/12/2024 13:52

0.32 v 0.35 actual spread level 2 .

[turbotrader2] 09/12/2024 13:51

Nice little buy of over £50k by the Doc!!

[gepetto100] 09/12/2024 11:57

Bones youre right there You pays your money and you takes your choice as they say

[bones698] 09/12/2024 11:30

Real spread 0.3126 0.324p tight spread 2v1 L2

Gepetto intelligence is in short supply in these markets it seems they would rather buy hype stocks with little substance .

[gepetto100] 09/12/2024 11:09

It doesnt take a great amount of intelligence to see that the board is confident in achieving these targets, and theyve strategically put these out I would also hazard a guess that by putting these out they are commercially farther down the road than is visible

[bones698] 09/12/2024 10:29

Some waking up to the positive buzz around apta management and confidence . A long way to go to get to the point those options even become available . Says it all

[someuwin] 09/12/2024 10:20

So current price 0.3p and these options vest at 1.4p, 2.0p and 2.5p. And they seem confident of achieving these targets..

"...The Group has set aggressive share price targets, which I am confident we can achieve given the calibre of customers we are dealing with and the progress we have made on a number of opportunities reported on recently, both commercially and scientifically. I am excited by the rapid progress the team are making; their focus and the quality of their work is paving the way for great things to come. Our platform technology is gaining increasing traction in the marketplace, and we are well positioned, with a skilful and knowledgeable team and our newly appointed Scientific Advisory board, to be able to take advantage of this."

[purchaseatthetop] 09/12/2024 07:40

9/10/23 options RNS
“The proposed options are designed to provide a material incentive to the Directors and other staff, but on stretching revenue and share price performance criteria as set out below, which include achieving returns of at least 4-times and up to 50-times the 1p option exercise price. 60% of the options only vest if the prevailing share price reaches 10-times the option exercise price.”

And

“Dr Arron Tolley has agreed to the cancellation of 700,000 existing options with an exercise price of 7.675p each and Dr David Bunka has agreed to the cancellation of 32,600 and 61,400 existing options with exercise prices of 15.54p and 7.675p each respectively.”

I think they can copy and paste the paragraph sny number of times in the future.